DE68902576D1 - Verwendung von thiadiazol-oxid-derivaten zur herstellung einer pharmazeutischen zusammensetzung fuer die behandlung von stoerungen der gastrointestinalen mobilitaet. - Google Patents

Verwendung von thiadiazol-oxid-derivaten zur herstellung einer pharmazeutischen zusammensetzung fuer die behandlung von stoerungen der gastrointestinalen mobilitaet.

Info

Publication number
DE68902576D1
DE68902576D1 DE8989108509T DE68902576T DE68902576D1 DE 68902576 D1 DE68902576 D1 DE 68902576D1 DE 8989108509 T DE8989108509 T DE 8989108509T DE 68902576 T DE68902576 T DE 68902576T DE 68902576 D1 DE68902576 D1 DE 68902576D1
Authority
DE
Germany
Prior art keywords
pharmaceutical composition
disorders
treatment
production
oxide derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8989108509T
Other languages
English (en)
Other versions
DE68902576T2 (de
Inventor
Jaswant S Gidda
Ivo Monkovic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of DE68902576D1 publication Critical patent/DE68902576D1/de
Application granted granted Critical
Publication of DE68902576T2 publication Critical patent/DE68902576T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE8989108509T 1988-05-12 1989-05-11 Verwendung von thiadiazol-oxid-derivaten zur herstellung einer pharmazeutischen zusammensetzung fuer die behandlung von stoerungen der gastrointestinalen mobilitaet. Expired - Fee Related DE68902576T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/193,025 US4829073A (en) 1988-05-12 1988-05-12 Thiadiazole oxides for treating gastrointestinal motility disorders

Publications (2)

Publication Number Publication Date
DE68902576D1 true DE68902576D1 (de) 1992-10-01
DE68902576T2 DE68902576T2 (de) 1993-01-21

Family

ID=22711984

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989108509T Expired - Fee Related DE68902576T2 (de) 1988-05-12 1989-05-11 Verwendung von thiadiazol-oxid-derivaten zur herstellung einer pharmazeutischen zusammensetzung fuer die behandlung von stoerungen der gastrointestinalen mobilitaet.

Country Status (7)

Country Link
US (1) US4829073A (de)
EP (1) EP0341722B1 (de)
JP (1) JPH01313424A (de)
AT (1) ATE79753T1 (de)
DE (1) DE68902576T2 (de)
ES (1) ES2034484T3 (de)
GR (1) GR3005563T3 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK60493D0 (da) * 1993-05-26 1993-05-26 Novo Nordisk As Kemiske forbindelser, deres fremstilling og anvendelse
ATE254609T1 (de) * 1995-05-18 2003-12-15 Zeria Pharm Co Ltd Aminothiazolderivate, sie enthaltende arzneimittel und zwischenprodukte in der herstellung dieser verbindungen
JP4153043B2 (ja) * 1996-10-24 2008-09-17 ゼリア新薬工業株式会社 置換ベンゾイルアミノチアゾール誘導体及びそれを含有する医薬
TWI256314B (en) * 2000-02-09 2006-06-11 Mitsubishi Pharma Corp Preventive-therapeutical medicament for gastroesophageal reflux disease
US20080287371A1 (en) * 2007-05-17 2008-11-20 Tranzyme Pharma Inc. Macrocyclic antagonists of the motilin receptor for modulation of the migrating motor complex

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3175201D1 (en) * 1980-04-30 1986-10-02 Merck & Co Inc Aminothiadiazoles as gastric secretion inhibitors
US4394508A (en) * 1980-06-07 1983-07-19 Bristol-Myers Company Chemical compounds
US4471122A (en) * 1981-03-03 1984-09-11 Bristol-Myers Company Thiadiazole histamine H2 -antagonists
US4567191A (en) * 1983-06-07 1986-01-28 Merck & Co., Inc. Amino-phenyl-thiadiazoledioxides as gastric secretion inhibitors

Also Published As

Publication number Publication date
GR3005563T3 (de) 1993-06-07
ES2034484T3 (es) 1993-04-01
EP0341722A3 (en) 1990-10-10
ATE79753T1 (de) 1992-09-15
JPH0480004B2 (de) 1992-12-17
JPH01313424A (ja) 1989-12-18
EP0341722B1 (de) 1992-08-26
DE68902576T2 (de) 1993-01-21
EP0341722A2 (de) 1989-11-15
US4829073A (en) 1989-05-09

Similar Documents

Publication Publication Date Title
CS161892A3 (en) Heterocyclic derivatives, process of their preparation and pharmaceuticalcompositions in which said derivatives are comprised
EP0317991A3 (de) 1-Aryl-3-chinolin- und 1-Aryl-3-isochinolin-carboxamide, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
ES8707947A1 (es) Un procedimiento para la preparacion de acidos 3-hidroxifenoxialquilenheterociclilcarboxilicos.
DE69327328T2 (de) Verwendund von norastemizol zur behandlung der allergischen rhinitis
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
DE68902576D1 (de) Verwendung von thiadiazol-oxid-derivaten zur herstellung einer pharmazeutischen zusammensetzung fuer die behandlung von stoerungen der gastrointestinalen mobilitaet.
IL85559A0 (en) Salt of a quinoline dicarboxylic acid,its manufacture and pharmaceutical compositions containing it
ATE110568T1 (de) Pharmazeutisches präparat zur behandlung des katarakts.
NO173991C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,5-ditiazocin-derivater
DK0497978T3 (da) Cephalosporinforbindelser og fremstilling heraf.
ATE38982T1 (de) Guanidinmethylcyclohexancarbonsaeure-derivate, verfahren zur herstellung und pharmazeutische mittel.
ATE121623T1 (de) Verwendung von quinazolinen zur herstellung eines arzneimittels zur behandlung und vorbeugung von arrhythmie.
EP0301466A3 (en) Uricosuric composition

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee